Clincosm LogoSign in Get a demo

invasive breast carcinoma

Showing 1 - 25 of 70
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Survivorship Biorepository

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +3 more
  • Biospecimen Collection
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Mar 15, 2023

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma Trial (drug,

Not yet recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +3 more
  • (no location specified)
Jan 24, 2023

Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma Trial in Worldwide (Anastrozole,

Active, not recruiting
  • Breast Ductal Carcinoma In Situ
  • +4 more
  • Anniston, Alabama
  • +1582 more
Jan 28, 2023

Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v6 Trial in Puerto Rico, United States

Active, not recruiting
Has Results
  • Invasive Breast Carcinoma
  • +3 more
  • Bevacizumab
  • +4 more
  • Mobile, Alabama
  • +525 more
Jan 28, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Suspended
  • Anatomic Stage I Breast Cancer AJCC v8
  • +23 more
  • Short-Term Fasting
  • Chemotherapy
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +13 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston

Completed
Has Results
  • Breast Atypical Ductal Hyperplasia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Tumor Biopsy in Creating Research Tissue Registry in

Recruiting
  • Inflammatory Breast Carcinoma
  • +2 more
  • Biospecimen Collection
  • +3 more
  • Houston, Texas
  • +4 more
Jan 6, 2023

Breast Adenocarcinoma, Invasive Breast Carcinoma, Resectable Breast Carcinoma Trial in Jacksonville (Biospecimen Collection,

Recruiting
  • Breast Adenocarcinoma
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

Breast Cancer, Node-positive Breast Cancer, Breast Adenocarcinoma Trial in Richmond, South Hill (External Beam Radiation

Active, not recruiting
  • Breast Cancer
  • +4 more
  • External Beam Radiation Therapy
  • +2 more
  • Richmond, Virginia
  • +1 more
Dec 16, 2022

Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma Trial in South Africa, United States (drug, other,

Active, not recruiting
Has Results
  • Estrogen Receptor Negative
  • +11 more
  • Mobile, Alabama
  • +1023 more
Dec 7, 2022

Decision Making in African American Women Diagnosed With Triple

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +21 more
  • Discussion
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +15 more
  • Bellevue, Nebraska
  • +3 more
Nov 30, 2022

Anatomic Stage 0 Breast Cancer AJCC v8, Bilateral Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in Chicago

Recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +5 more
  • Intraoperative Imaging
  • Lumpectomy
  • Chicago, Illinois
  • +3 more
Nov 30, 2022

Hypofractionated Radiation-Induced DNA Damage in Breast Cancer

Not yet recruiting
  • Breast Carcinoma
  • Invasive Breast Carcinoma
  • Biopsy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 28, 2022

Breast Cancer, Ductal Carcinoma, Invasive Breast Carcinoma Trial in Tampa (Talimogene laherparepvec, Paclitaxel)

Active, not recruiting
Has Results
  • Breast Cancer
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

Terminated
  • Estrogen Receptor Positive
  • +16 more
  • Biopsy of Breast
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022

ResiduAl Cancer With Liquid Biopsy Evaluation

Recruiting
  • Bladder Carcinoma
  • +14 more
  • Guardant Reveal
  • Redwood City, California
    Redwood City
Sep 7, 2022

Barriers Associated With Timely Adjuvant Chemotherapy

Active, not recruiting
  • Invasive Breast Carcinoma
  • Interview
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 25, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +8 more
  • Birmingham, Alabama
  • +911 more
Aug 23, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Orange, California
  • +15 more
Aug 23, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ Trial in

Not yet recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Houston, Texas
  • +2 more
Aug 17, 2022

Ductal Breast Carcinoma In Situ, Estrogen Receptor Positive, Invasive Breast Carcinoma Trial in United States (Accelerated

Active, not recruiting
Has Results
  • Ductal Breast Carcinoma In Situ
  • +6 more
  • Accelerated Partial Breast Irradiation
  • +2 more
  • Gilbert, Arizona
  • +9 more
Jul 20, 2022

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +19 more
  • Quality-of-Life Assessment
  • +5 more
  • Hamilton, New Jersey
  • +3 more
Jul 27, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic HER2 Negative Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Sacituzumab Govitecan
  • Anchorage, Alaska
  • +295 more
Jul 20, 2022